Literature DB >> 2672021

History of BCG and its substrains.

R Crispen1.   

Abstract

Mesh：

Substances：

Year:  1989        PMID： 2672021

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN： 0361-7742


× No keyword cloud information.
  8 in total

Review 1.  Intravesical therapy for urothelial carcinoma of the urinary bladder: a critical review.

Authors:  Daher C Chade; Shahrokh F Shariat; Guido Dalbagni
Journal:  Int Braz J Urol       Date:  2009 Nov-Dec       Impact factor: 1.541

2.  Separation of Mycobacterium bovis BCG from Mycobacterium tuberculosis and Mycobacterium bovis by using high-performance liquid chromatography of mycolic acids.

Authors:  M M Floyd; V A Silcox; W D Jones; W R Butler; J O Kilburn
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

3.  Neutrophil stimulation with Mycobacterium bovis bacillus Calmette-Guerin (BCG) results in the release of functional soluble TRAIL/Apo-2L.

Authors:  Troy J Kemp; Aaron T Ludwig; James K Earel; Jill M Moore; Rebecca L Vanoosten; Bonita Moses; Kevin Leidal; William M Nauseef; Thomas S Griffith
Journal:  Blood       Date:  2005-07-21       Impact factor: 22.113

Review 4.  Update on intravesical agents for non-muscle-invasive bladder cancer.

Authors:  Shahrokh F Shariat; Daher C Chade; Pierre I Karakiewicz; Douglas S Scherr; Guido Dalbagni
Journal:  Immunotherapy       Date:  2010-05       Impact factor: 4.196

Review 5.  BCG in the treatment of superficial cancer of the bladder: a review.

Authors:  S Friberg
Journal:  Med Oncol Tumor Pharmacother       Date:  1993

Review 6.  Role of neutrophils in BCG immunotherapy for bladder cancer.

Authors:  Mark P Simons; Michael A O'Donnell; Thomas S Griffith
Journal:  Urol Oncol       Date:  2008 Jul-Aug       Impact factor: 3.498

7.  Gene Expression in Human Polymorphonuclear Neutrophils (PMNs) Stimulated by Bacillus Calmette-Guérin (BCG).

Authors:  Kangkang Liu; Erlin Sun; Lining Wang; Xuewu Nian; Chengquan Ma
Journal:  Inflammation       Date:  2020-12       Impact factor: 4.092

Review 8.  BCG turns 100: its nontraditional uses against viruses, cancer, and immunologic diseases.

Authors:  Alok K Singh; Mihai G Netea; William R Bishai
Journal:  J Clin Invest       Date:  2021-06-01       Impact factor: 19.456
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.